Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Ureterorenoscope System

K-Number: K201293 · 2020-07-24

Decision Date2020-07-24
Product CodeFGB
Advisory CommitteeGU
DecisionSubstantially Equivalent

Device Summary

Ureterorenoscope System is the device name listed in this FDA 510(k) record. The listed applicant is Shanghai AnQing Medical Instrument Co., Ltd.. It received FDA 510(k) clearance on 2020-07-24 under 510(k) number K201293. The device is classified under product code FGB. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Ureterorenoscope System?

Ureterorenoscope System is a medical device that received FDA 510(k) clearance on 2020-07-24. The listed applicant is Shanghai AnQing Medical Instrument Co., Ltd.. The 510(k) number is K201293.

When did Ureterorenoscope System receive FDA 510(k) clearance?

Ureterorenoscope System received FDA 510(k) clearance on 2020-07-24, under 510(k) number K201293.

Who is the listed applicant for Ureterorenoscope System?

The FDA 510(k) record lists Shanghai AnQing Medical Instrument Co., Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Ureterorenoscope System?

The FDA product code for Ureterorenoscope System is FGB.

Other records listing Shanghai AnQing Medical Instrument Co., Ltd. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 14 devices →

Related Devices (Code: FGB)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.